Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.73 |
| ▸ | NAAA | Q02083 | 2/20 | 0.71 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.66 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.66 |
| ▸ | MLYCD | O95822 | 1/20 | 0.66 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.66 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.66 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.66 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.66 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.66 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.66 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.66 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.66 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | THRA | P10827 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10994444 | 1.00 | L3MBTL1 (0.73) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL5694370 | 1.00 | L3MBTL1 (0.73) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL10595825 | 1.00 | L3MBTL1 (0.73) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL13509604 | 0.98 | L3MBTL1 (0.71) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL6359381 | 0.93 | HDAC3 (0.71) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL9504178 | 0.91 | L3MBTL1 (0.86) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL9491749 | 0.91 | HDAC3 (0.76) | HDAC3HDAC1HDAC2HDAC4HDAC7 | |
| SCHEMBL845966 | 0.91 | L3MBTL1 (0.86) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL11719128 | 0.91 | L3MBTL1 (0.62) | L3MBTL1NAAAHDAC3HDAC1HDAC2 | |
| SCHEMBL6535660 | 0.91 | L3MBTL1 (0.86) | L3MBTL1NAAAHDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115557849-A | Method for synthesizing imide compound under induction of NBS and water by visible light | 西南大学 | 2023-01-03 | — | — | CN | disclosed |
| US-8093227-B2 | Monosaccharide compounds and methods therefor | ALCHEMIA PTY LTD (AU) | 2012-01-10 | — | — | US | disclosed |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | ALCHEMIA PTY LTD. (AU) | 2010-07-22 | — | — | US | disclosed |
| US-7417129-B2 | Combinatorial libraries of monosaccharides | ALCHEMIA PTY LTD (AU) | 2008-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | SLC5A1, UGGT1, MRPL21 | L3MBTL1 2971/4885NAAA 2912/4885HDAC3 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.